{"id":"W3173323203","doi":"10.2337/db21-130-lb","title":"130-LB: Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease","year":2021,"lang":"en","type":"article","venue":"Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dapagliflozin; Medicine; Type 2 diabetes; Kidney disease; Hazard ratio; Internal medicine; Albuminuria; Diabetes mellitus; Prediabetes; Placebo; Glycemic; Renal function; Incidence (geometry); Cohort; Endocrinology; Confidence interval","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001433287,0.0004696959,0.001251213,0.0002478042,0.0001349397,0.0006671816,0.0003858329,0.0006886563,0.004471194],"category_scores_gemma":[0.002059616,0.000246374,0.001217006,0.0003465586,0.0002365168,0.0003350977,0.0003924093,0.001552248,0.0006821011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000333814,"about_ca_system_score_gemma":0.0005754292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001311398,"about_ca_topic_score_gemma":0.002043227,"domain_scores_codex":[0.9994105,0.0003266416,0.00003889643,0.00007167894,0.0001022309,0.0000500636],"domain_scores_gemma":[0.9994337,0.0002147497,0.000147474,0.0000286637,0.00004321874,0.000132106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6906372,0.00426067,0.03366572,0.003564792,0.006351698,0.0001062609,0.00006255896,0.001219767,0.003870616,0.000711751,0.01822884,0.2373202],"study_design_scores_gemma":[0.6893148,0.0573607,0.2181065,0.0009236088,0.009500345,0.0004012446,0.00005806023,0.005231997,0.001707346,0.001498154,0.0158268,0.00007039775],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9243448,0.04298731,0.002610205,0.005188509,0.00163264,0.001555447,0.008543363,0.0005006237,0.01263699],"genre_scores_gemma":[0.9767801,0.007396561,0.002355973,0.002590667,0.001130336,0.001034499,0.004675702,0.00002664207,0.004009529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004471194,"threshold_uncertainty_score":0.01495761,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00487346716573544,"score_gpt":0.207753063766711,"score_spread":0.2028795966009755,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}